GGrantIndex
Sort

172,184 grants matching inflammation

Protein biomarkers to predict pain outcomes after total pancreatectomy with islet autotransplant

$774,125
Melena D. Bellin · University Of Minnesota · R01 · FY2023 · DK

HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues

$774,121
David Mitchell Smith · University Of California, San Diego · R01 · FY2025 · DK

Identifying Unique Neural and Inflammatory Mechanisms of Depression in People Living with HIV

$774,090
John O Brooks · University Of California Los Angeles · R01 · FY2025 · MH

Mental Stress and Myocardial Ischemia after MI: Sex Differences, Mechanisms and Prognosis

$774,074
Viola Vaccarino Vaccarino · Emory University · R01 · FY2023 · HL

Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life

$774,072
Jordana B. Cohen · University Of Pennsylvania · R01 · FY2023 · AG

Role of the complement C3a receptor on immune and non immune intestinal barrier functions and microbiota in colorectal cancer development

$774,054
Silvia Guglietta · Medical University Of South Carolina · R01 · FY2025 · CA

Probing the role of adenosine pathway in SIV pathogenesis

$774,038
Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI

MRI Phenotyping of Early BPD and Prediction of Outcomes

$774,028
Jason C Woods · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL

Aspirin, Lp(a) and Primary Prevention of Cardiovascular Events

$774,023
Sotirios Tsimikas · University Of California, San Diego · R01 · FY2025 · HL

Mechanism of immune response to muscle-directed AAV gene transfer

$774,002
Roland W. Herzog · Indiana University Indianapolis · R01 · FY2023 · AI

Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease

$773,997
Carlos Fernandez Hernando · Yale University · R01 · FY2024 · HL

Induced tolerogenic dendritic cell therapy of allergic diseases

$773,988
Ulrich H Von Andrian · Massachusetts General Hospital · U19 · FY2012 · AI

Genetics-informed dissection of human brain cell-cell communication in Alzheimer's disease progression

$773,979
Bingshan Li · Vanderbilt University · R01 · FY2025 · AG

A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer

$773,972
Ihab M Hajjar · Emory University · R01 · FY2017 · AG

Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women

$773,957
Ten㉠T Lewis · Emory University · R01 · FY2022 · HL

Early Life Adversity and Adulthood Health: The Role of Pubertal Development

$773,950
Maria E. Bleil · University Of Washington · R01 · FY2017 · HL

IDOL and dyslipidemia in cardiovascular diseases

$773,938
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2022 · HL

IDOL and dyslipidemia in cardiovascular diseases

$773,938
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2019 · HL

IDOL and dyslipidemia in cardiovascular diseases

$773,938
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2020 · HL

IDOL and dyslipidemia in cardiovascular diseases

$773,938
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2021 · HL

Calculating the Components of Work of Breathing in Neonates with Bronchopulmonary Dysplasia

$773,916
Alister Bates · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL

HIV, gestational diabetes and TB in pregnancy

$773,903
Jyoti S Mathad · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI

LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics

$773,901
Fernando Holguin · University Of Colorado Denver · R33 · FY2023 · HL

The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)

$773,895
Thomas Ekkehard Ritz · Southern Methodist University · R01 · FY2018 · HL

The Role Of Nrf2 In Susceptibility To Hyperoxic Lung Injury

$773,892
Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES